Innovative Eyewear Inc

Innovative Eyewear Inc(LUCY)股票分析

$0.828

+0.007 (+0.83%)收盤時

Loading chart…
最高
0.830
開盤
0.810
成交量加權均價
0.82
成交量
57.47K
市值
7.75M
最低
0.804
成交金額
47.16K
企業價值/稅息折舊攤銷前利潤(TTM)
-0.13

Innovative Eyewear, Inc. develops and sells smart eyeglasses and sunglasses, which are designed to allow customers to remain connected to their digital lives, while also offering prescription eyewear and sun protection. The smart eyewear products enable the wearer to listen to music, take and make calls, and use voice assistants and ChatGPT to perform many common smartphone tasks hands-free. It has created a smart upgrade for all four of the major types of eyewear: prescription eyeglasses, ready-to-wear sunglasses, safety glasses, and sports glasses. Its brands include Lucyd, Nautica, Eddie Bauer and Reebok brands. Its first commercial product, Lucyd Lyte, enables the wearer to remain connected to their digital lives. Its product offering consists of approximately 26 different models, which offer a similar amount of style variety as many traditional eyewear collections. All styles are each available with 100+ different lens types. It has over 115 patents and applications.

lucyd.co

AI 分析 of Innovative Eyewear Inc (LUCY)

持有

Innovative Eyewear Inc (LUCY) is currently not a strong buy. The stock is trading at $0.83, which is significantly lower than its 52-week high of $2.02, indicating a substantial decline of 58.92%. Additionally, the RSI is at 43.22, suggesting that the stock is nearing oversold territory but not yet at a strong buy signal. The forward P/E ratio is currently at 0, indicating uncertainty in future earnings, and the company has reported consistent losses, with a net income of -$2,309,368 in Q1 2026. The main risk is the ongoing negative net margins, which stand at -298.54% for Q1 2026, reflecting serious profitability challenges. Therefore, while there are signs of revenue growth, the overall financial health and profitability concerns suggest that holding is the best course of action for now.

估值指標

Innovative Eyewear Inc(LUCY)目前預期本益比為 0.00,5 年平均預期本益比為 -1.42。

預期本益比

高估
5 年均值 P/E
-1.42
目前P/E
0.00
高估
-0.38
低估
-2.45

預期 EV/EBITDA

合理
5 年均值 EV/EBITDA
2.71
目前EV/EBITDA
-0.13
高估
21.64
低估
-16.22

預期股價營收比

合理
5 年均值 P/S
4.02
目前P/S
0.33
高估
11.54
低估
-3.49

Alphio AI 對 LUCY 的價格情境

情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

樂

樂觀

樂觀 · 25%LUCY

$4.12

情境價格

基

基準

基準 · 50%LUCY

$3.43

情境價格

悲

悲觀

悲觀 · 25%LUCY

$2.04

情境價格

事件時間軸

2026-10-06 (ET)

08:30:00

Innovative Eyewear Reports Q3 Net Sales of $1.04M

2026-09-08 (ET)

08:30:00

Innovative Eyewear Partners with Directed Electronics for Exclusive Distribution in Australia and New Zealand

2026-09-03 (ET)

08:30:00

Innovative Eyewear Reports Q3 2026 Revenue Surpassing $1M for the First Time

2026-08-24 (ET)

08:30:00

Innovative Eyewear Forms Strategic Alliance with HTC

08:00:00

Innovative Eyewear Launches Lucyd Armor Products in Major US Retailer

資訊

LUCY 常見問題 —— 由 Alphio AI 解答

Innovative Eyewear, Inc. develops and sells smart eyeglasses and sunglasses, which are designed to allow customers to remain connected to their digital lives, while also offering prescription eyewear and sun protection. The smart eyewear products enable the wearer to listen to music, take and make calls, and use voice assistants and ChatGPT to perform many common smartphone tasks hands-free. It has created a smart upgrade for all four of the major types of eyewear: prescription eyeglasses, ready-to-wear sunglasses, safety glasses, and sports glasses. Its brands include Lucyd, Nautica, Eddie Bauer and Reebok brands. Its first commercial product, Lucyd Lyte, enables the wearer to remain connected to their digital lives. Its product offering consists of approximately 26 different models, which offer a similar amount of style variety as many traditional eyewear collections. All styles are each available with 100+ different lens types. It has over 115 patents and applications. It operates in the Healthcare sector (OPHTHALMIC GOODS industry).

Innovative Eyewear Inc (LUCY) is currently not a strong buy. The stock is trading at $0.83, which is significantly lower than its 52-week high of $2.02, indicating a substantial decline of 58.92%. Additionally, the RSI is at 43.22, suggesting that the stock is nearing oversold territory but not yet at a strong buy signal. The forward P/E ratio is currently at 0, indicating uncertainty in future earnings, and the company has reported consistent losses, with a net income of -$2,309,368 in Q1 2026. The main risk is the ongoing negative net margins, which stand at -298.54% for Q1 2026, reflecting serious profitability challenges. Therefore, while there are signs of revenue growth, the overall financial health and profitability concerns suggest that holding is the best course of action for now.

暫無貼文

註冊或登入後參與討論

相關文章

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易